CompletedNCT00237666
Ziprasidone for depression in people with bipolarity type II
About this title
Read the official source — NCT00237666Researchers studied Ziprasidone to find out how it affected depression symptoms in people with bipolarity type II during a depressive episode.
Medication studyAges 18+United States
Understand this study
What did researchers investigate?
Researchers studied Ziprasidone to find out how it affected depression symptoms in people with bipolarity type II during a depressive episode.
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- New York and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateFebruary 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- The Medical Research Network
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00237666
- Official title
Show the full official title
An Open-Label, Flexible-Dose Trial of the Safety and Efficacy of Geodon in Non-Rapid-Cycling Bipolar II Patients With Major Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New York · Plano
Interested in joining this study?
Questions about this study
What did researchers investigate?
Researchers studied Ziprasidone to find out how it affected depression symptoms in people with bipolarity type II during a depressive episode.
Who is behind this study?
The study sponsor is The Medical Research Network.
Did this study involve medication?
Yes. The study involved medication, including Ziprasidone.
Who was this study for?
Listed age limits: from 18 years.
